Ferroptosis in the tumor immune microenvironment: A double-edged sword in immunotherapy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189646
DOI: 10.1016/j.bbcan.2026.189646 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Ruiye Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing 100006, China; Labor…. Hauptthemen laut MEDLINE: Ferroptosis, Tumor Microenvironment, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China National Outstanding Youth Science Fund Project, China Postdoctoral Science Foundation, Capital Medical University.
Abstract (Originalsprache)
Ferroptosis, an iron-dependent form of programmed cell death, has recently garnered significant attention for its intricate involvement in the tumor immune microenvironment (TIME) and its implications in tumor immunotherapy. This review comprehensively explores the molecular mechanisms underlying ferroptosis and its regulation within tumor cells, highlighting the complex dual effects of ferroptosis on immune cell functions in TIME. While ferroptosis enhances cancer cell immunogenicity and promotes antitumor immunity through immune cell activation, it may also impair immune responses by disrupting T/B/NK cell functions and macrophage polarization. Critically, ferroptotic cells release damage-associated molecular patterns (DAMPs) such as high-mobility group box 1 (HMGB1) and oxidized phospholipids, triggering inflammation via receptors like Toll-like receptor 4 (TLR4) and activating inflammasomes. This review explores how this ferroptosis-driven inflammatory cascade reshapes TIME components, highlighting its potential to sensitize tumors to immunotherapy. Targeting ferroptosis pathways may overcome resistance to immune checkpoint blockade. However, cancer cells develop ferroptosis resistance through metabolic adaptations and antioxidant systems, complicating therapeutic strategies. Future studies should unravel context-specific regulatory networks linking ferroptosis, inflammation, and immunity to optimize immunotherapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing 100006, China; Laboratory for Clinical Medicine, Capital Medical University, Beijing 10000…
- State key laboratry of medical proteomics, National center for protein sciences (Beijing), institute of lifeomics, Beijing 100006, China.
Förderung
- National Natural Science Foundation of China National Outstanding Youth Science Fund Project
- China Postdoctoral Science Foundation
- Capital Medical University
- National Natural Science Foundation of China
Zitieren
APA
Yang, R., Zhu, T., Jiang, J., Deng, M., & Miao, J. (2026). Ferroptosis in the tumor immune microenvironment: A double-edged sword in immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189646. https://doi.org/10.1016/j.bbcan.2026.189646
Vancouver
Yang R, Zhu T, Jiang J, Deng M, Miao J. Ferroptosis in the tumor immune microenvironment: A double-edged sword in immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189646. doi:10.1016/j.bbcan.2026.189646
BibTeX
@article{Yang2026,
author = {Yang, Ruiye and Zhu, Tianyu and Jiang, Junyi and Deng, Mengqi and Miao, Jinwei},
title = {Ferroptosis in the tumor immune microenvironment: A double-edged sword in immunotherapy},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189646},
doi = {10.1016/j.bbcan.2026.189646}
}
EUVIMED